Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma
✍ Scribed by David M. Nanus; Alexandria Garino; Matthew I. Milowsky; Maureen Larkin; Janice P. Dutcher
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 204 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Renal cell carcinoma (RCC) is the most common type of kidney cancer and follows an unpredictable disease course. To improve prognostication, a better understanding of critical genes associated with disease progression is required. The objective of this review was to focus attention on 2
## Abstract ## BACKGROUND High‐quality external validation studies have recently been highlighted to be of paramount importance for proper translation of prognostic markers into the clinical setting. To that end, the authors examined associations of the insulin‐like growth factor‐II mRNA binding p
## Abstract A population‐based case‐control study of risk factors for renal‐cell carcinoma was conducted in Denmark from 1989 to 1992. A total of 368 histologically verified cases and 396 controls were included. Information on weight, height, physical activity and reproductive factors were collecte